Drug Shortage Report for BREVICON 1/35 TABLETS (21-DAY PACK)

Last updated on 2023-04-26 History
Report ID 188193
Drug Identification Number 02189054
Brand name BREVICON 1/35 TABLETS (21-DAY PACK)
Common or Proper name BREVICON
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ETHINYL ESTRADIOL NORETHINDRONE
Strength(s) 0.035MG 1MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 21's
ATC code G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-03-29
Actual start date 2023-03-29
Estimated end date 2023-04-25
Actual end date 2023-04-25
Shortage status Resolved
Updated date 2023-04-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-04-26 English Compare
v6 2023-04-25 French Compare
v5 2023-04-25 English Compare
v4 2023-03-30 English Compare
v3 2023-03-29 French Compare
v2 2023-03-29 English Compare
v1 2023-03-28 English Compare

Showing 1 to 7 of 7